89bio, Inc. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
89bio, Inc. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$182.78 million for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2025-08-08
- 89bio, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-06-30 was -$111.50M.
- 89bio, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$71.28M.
- 89bio, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was -$118.35M.
- 89bio, Inc. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$149.07M.
- 89bio, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$367.08M.
- 89bio, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$142.19M.
- 89bio, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$102.03M.
- 89bio, Inc. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$90.12M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 8 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 11 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|---|---|
| 2025-06-30 | -$111.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$182.78M 10-Q · filed 2025-08-08 | -$301.13M derived: sum of 3 quarters · filed 2025-08-08 | -$450.21M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2025-03-31 | -$71.28M 10-Q · filed 2025-05-02 | -$189.63M derived: sum of 2 quarters · filed 2025-05-02 | -$338.70M derived: sum of 3 quarters · filed 2025-05-02 | -$386.67M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-12-31 | -$118.35M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$267.43M derived: sum of 2 quarters · filed 2025-02-27 | -$315.40M derived: sum of 3 quarters · filed 2025-08-08 | -$367.08M 10-K · filed 2025-02-27 | ||
| 2024-09-30 | -$149.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$197.04M derived: sum of 2 quarters · filed 2025-08-08 | -$248.72M 10-Q · filed 2024-11-07 | -$288.96M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-06-30 | -$47.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$99.65M 10-Q · filed 2025-08-08 | -$139.89M derived: sum of 3 quarters · filed 2025-08-08 | -$174.61M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | -$51.68M 10-Q · filed 2025-05-02 | -$91.92M derived: sum of 2 quarters · filed 2025-05-02 | -$126.64M derived: sum of 3 quarters · filed 2025-05-02 | -$165.03M derived: sum of 4 quarters · filed 2025-05-02 | ||
| 2023-12-31 | -$40.23M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$74.96M derived: sum of 2 quarters · filed 2025-02-27 | -$113.35M derived: sum of 3 quarters · filed 2025-02-27 | -$142.19M 10-K · filed 2025-02-27 | ||
| 2023-09-30 | -$34.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$73.12M derived: sum of 2 quarters · filed 2024-11-07 | -$101.95M 10-Q · filed 2024-11-07 | -$126.56M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-06-30 | -$38.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$67.23M 10-Q · filed 2024-08-05 | -$91.83M derived: sum of 3 quarters · filed 2025-02-27 | -$118.64M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2023-03-31 | -$28.84M 10-Q · filed 2024-05-09 | -$53.44M derived: sum of 2 quarters · filed 2025-02-27 | -$80.24M derived: sum of 3 quarters · filed 2025-02-27 | -$105.30M derived: sum of 4 quarters · filed 2025-02-27 | ||
| 2022-12-31 | -$24.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$51.41M derived: sum of 2 quarters · filed 2025-02-27 | -$76.46M derived: sum of 3 quarters · filed 2025-02-27 | -$102.03M 10-K · filed 2025-02-27 | ||
| 2022-09-30 | -$26.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$51.86M derived: sum of 2 quarters · filed 2023-11-09 | -$77.42M 10-Q · filed 2023-11-09 | -$103.71M derived: sum of 4 quarters · filed 2024-03-01 | ||
| 2022-06-30 | -$25.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$50.62M 10-Q · filed 2023-08-09 | -$76.91M derived: sum of 3 quarters · filed 2024-03-01 | -$105.24M derived: sum of 4 quarters · filed 2024-03-01 | ||
| 2022-03-31 | -$25.57M 10-Q · filed 2023-05-08 | -$51.85M derived: sum of 2 quarters · filed 2024-03-01 | -$80.18M derived: sum of 3 quarters · filed 2024-03-01 | -$100.91M derived: sum of 4 quarters · filed 2024-03-01 | ||
| 2021-12-31 | -$26.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$54.62M derived: sum of 2 quarters · filed 2024-03-01 | -$75.34M derived: sum of 3 quarters · filed 2024-03-01 | -$90.12M 10-K · filed 2024-03-01 | ||
| 2021-09-30 | -$28.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$49.05M derived: sum of 2 quarters · filed 2022-11-10 | -$63.83M 10-Q · filed 2022-11-10 | -$76.42M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | -$20.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$35.51M 10-Q · filed 2022-08-11 | -$48.09M derived: sum of 3 quarters · filed 2022-08-11 | -$62.69M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$14.78M 10-Q · filed 2022-05-12 | -$27.36M derived: sum of 2 quarters · filed 2022-05-12 | -$41.97M derived: sum of 3 quarters · filed 2022-05-12 | -$53.74M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$27.18M derived: sum of 2 quarters · filed 2022-03-24 | -$38.95M derived: sum of 3 quarters · filed 2022-03-24 | -$49.50M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | -$14.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$26.37M derived: sum of 2 quarters · filed 2021-11-12 | -$36.92M 10-Q · filed 2021-11-12 | -$56.20M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | -$11.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | -$22.32M 10-Q · filed 2021-08-13 | -$41.60M derived: sum of 3 quarters · filed 2021-08-13 | -$60.32M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | -$10.54M 10-Q · filed 2021-05-14 | -$29.83M derived: sum of 2 quarters · filed 2021-05-14 | -$48.55M derived: sum of 3 quarters · filed 2021-05-14 | -$63.52M derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2019-12-31 | -$19.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$38.01M derived: sum of 2 quarters · filed 2021-03-25 | -$52.98M derived: sum of 3 quarters · filed 2021-03-25 | -$57.42M 10-K · filed 2021-03-25 | ||
| 2019-09-30 | -$18.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$33.70M derived: sum of 2 quarters · filed 2020-11-13 | -$38.14M 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | -$14.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$19.41M 10-Q · filed 2020-08-13 | ||||
| 2019-03-31 | -$4.44M 10-Q · filed 2020-05-13 | |||||
| 2018-12-31 | -$16.18M 10-K · filed 2020-03-18 | |||||
| 2018-09-30 | -$11.54M 10-Q · filed 2019-12-18 |